A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block

Anesthesia and Analgesia

Volumn 87, Issue 6, 1998, Pages 1316-1319

  Klein, Stephen M ^a,b   Greengrass, Roy A ^a   Steele, Susan M ^a   D'Ercole, Fran J ^a   Speer, Kevin P ^a   Gleason, David H ^a   Delong, Elizabeth R ^a   Warner, David S ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

ADULT; ARTICLE; BRACHIAL PLEXUS; BRACHIAL PLEXUS ANESTHESIA; CLINICAL TRIAL; DRUG SAFETY; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SHOULDER;

EID: 0031765735     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199812000-00019     Document Type: Article

References (6)

1. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989;69:563-9.
2. Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg 1988;67:1053-8.
3. Winnie AP. Interscalene brachial plexus block. Anesth Analg 1970;49:455-66.
4. Brown DL. Regional anesthesia and analgesia. Philadelphia: WB Saunders, 1996:260-4.
5. Wiener DM, Speer KP. The deltoid sign [letter]. Anesth Analg 1994;79:192.
6. Hickey R, Huffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology 1991;74:639-42.